Scotia Capital Inc. Edwards Lifesciences Corp Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $46,702 - $52,247	-554 Reduced 2.82%	19,099 $1.76 Million
Q1 2024 May 14, 2024	SELL	$72.54 - $95.56 $198,251 - $261,165	-2,733 Reduced 12.21%	19,653 $1.88 Million
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $55,847 - $70,372	905 Added 4.21%	22,386 $1.71 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $48,980 - $66,019	-707 Reduced 3.19%	21,481 $1.49 Million
Q2 2023 Aug 03, 2023	SELL	$81.41 - $94.33 $82,712 - $95,839	-1,016 Reduced 4.38%	22,188 $2.09 Million
Q1 2023 May 11, 2023	BUY	$74.26 - $84.51 $253,597 - $288,601	3,415 Added 17.26%	23,204 $1.92 Million
Q4 2022 Feb 09, 2023	BUY	$68.3 - $87.44 $606,777 - $776,816	8,884 Added 81.47%	19,789 $1.48 Million
Q3 2022 Nov 10, 2022	BUY	$82.37 - $107.29 $12,684 - $16,522	154 Added 1.43%	10,905 $901,000
Q2 2022 Aug 05, 2022	SELL	$86.5 - $128.27 $966,464 - $1.43 Million	-11,173 Reduced 50.96%	10,751 $1.02 Million
Q1 2022 May 09, 2022	SELL	$101.96 - $128.34 $77,081 - $97,025	-756 Reduced 3.33%	21,924 $2.58 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $186,041 - $228,559	1,749 Added 8.36%	22,680 $2.94 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $4,322 - $5,155	-42 Reduced 0.2%	20,931 $2.37 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $27,499 - $34,361	328 Added 1.59%	20,973 $2.17 Million
Q1 2021 May 06, 2021	BUY	$78.68 - $90.67 $101,261 - $116,692	1,287 Added 6.65%	20,645 $1.73 Million
Q4 2020 Feb 11, 2021	BUY	$71.69 - $91.23 $54,914 - $69,882	766 Added 4.12%	19,358 $1.77 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $1.25 Million - $1.63 Million	18,592 New	18,592 $1.48 Million
Q2 2020 Aug 11, 2020	SELL	$57.54 - $76.95 $328,553 - $439,384	-5,710 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $37,840 - $58,482	722 Added 14.47%	5,710 $1.08 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $191,725 - $219,508	2,674 Added 115.56%	4,988 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $142,426 - $174,545	2,314 New	2,314 $509,000
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $256,982 - $327,879	-6,910 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$33.79 - $39.39 $5,237 - $6,105	155 Added 2.29%	6,910 $779,000
Q3 2017 Nov 14, 2017	SELL	$36.29 - $38.83 $9,072 - $9,707	-250 Reduced 3.57%	6,755 $738,000
Q2 2017 Aug 15, 2017	BUY	N/A	7,005	7,005 $828,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account